Table 6 Haemoglobin levels for each of the study arms, aggregated over the 2-year trial period
|  | Control | HI | LSM | HI + LSM | |||
|---|---|---|---|---|---|---|---|
Outcomes | Mean value observed (95% CI) | Mean value observed (95% CI) | Estimated effect sizea (95% CI) | Mean value observed (95% CI) | Estimated effect sizea (95% CI) | Mean value observed (95% CI) | Estimated effect sizea (95% CI) |
Hb, g/dL, women 15–49 years | 12.31 (12.15, 12.47) | 12.61 (12.49, 12.72) | − 0.10 (− 0.42, 0.21) | 12.21 (12.10, 12.31) | − 0.11 (− 0.37, 0.15) | 12.46 (12.31, 12.61) | 0.01 (− 0.30, 0.33) |
Hb, g/dL, children 6–59 months | 10.80 (10.59, 11.01) | 11.29 (11.16, 11.42) | 0.17 (− 0.22, 0.56) | 10.68 (10.55, 10.81) | − 0.02 (− 0.34, 0.31) | 11.08 (10.89, 11.27) | 0.28 (− 0.15, 0.71) |
Hb, g/dL, children 6–23 months | 10.61 (10.26, 10.96) | 10.86 (10.65, 11.07) | 0.08 (− 0.44, 0.61) | 10.14 (9.93, 10.35) | − 0.40 (− 0.90, 0.10) | 10.61 (10.28, 10.95) | − 0.14 (− 0.70, 0.42) |